Search Results - "Eliaçık, E"

PP-021 ASHERMAN SYNDROME WITH FACTOR 7 DEFICIENCY: CASE REPORT by Malkan, Ü.Y, Güneş, G, Eliaçık, E, Işık, A, Sayınalp, N, Özcebe, O.İ, Aksu, S

Get full text

PP-020 AN ESSENTIAL THROMBOCYTOSIS CASE, WHICH TRANSFORMED TO ACUTE MYELOID LEUKEMIA AFTER 12 YEARS by Malkan, Ü.Y, Güneş, G, Eliaçık, E, Işık, A, Sayınalp, N, Özcebe, O.İ, Haznedaroğlu, İ.C

Get full text

PP-039 COEXISTENCE OF FACTOR X DEFICIENCY AND PROTHROMBOTIC MTHFR HOMOZYGOTE MUTATION IN PREGNANCY: CASE REPORT by Malkan, Ü.Y, Güneş, G, Eliaçık, E, Işık, A, Sayınalp, N, Haznedaroğlu, İ.C, Aksu, S

Get full text

PP-043 GIANT HEMOPHILIC PSEUDOTUMOR OF THE ILIOPSOAS: CASE REPORT by Malkan, Ü.Y, Günes, G, Eliaçık, E, Aksu, A. Işık S, Atilla, B, Büyükaşık, Y

Get full text

PP-035 REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE DEVELOPING IN POST-TRANSPLANT FIFTH YEAR by Güneş, G, Malkan, Ü.Y, Işık, A, Eliaçık, E, Demiroğlu, H, Özcebe, O.İ, Göker, H, Sayınalp, N, Aksu, S

Get full text

PP-056 HYPEREOSINOPHILIC SYNDROME: CASE REPORT by Malkan, Ü.Y, Güneş, G, Okay, M, Eliaçık, E, Işık, A, Sayinalp, N, Göker, H, Özcebe, O.İ, Demiroğlu, H

Get full text

PP-057 IMATINIB-INDUCED ACUTE RHABDOMYOLYSIS IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENT by Malkan, Ü.Y, Güneş, G, Eliaçık, E, Işık, A, Sayınalp, N, Göker, H, Demiroğlu, H, Aksu, S, Büyükaşık, Y, Haznedaroğlu, İ.C

Get full text

PP-063 TWO CASES WITH PRIMARY IMMUNE DEFICIENCY AND NEOPLASTIC LYMPHOID PROLIFERATION by Malkan, Ü.Y, Günes, G, Eliaçık, E, Işık, A, Sayinalp, N, Aksu, S, Göker, H, Demiroğlu, H

Get full text

PP-038 TREATMENT OF CHRONIC MYELOID LEUKEMIA IN PREGNANCY by Güneş, G, Malkan, Ü.Y, Işık, A, Eliaçık, E, Göker, H, Haznedaroğlu, İ.C, Özcebe, O.İ, Büyükaşık, Y, Sayinalp, N, Aksu, S

Get full text

PP-036 HODGKIN TRANSFORMATION IN CHRONIC LYMPHOCYTIC LEUKEMIA by Güneş, G, Malkan, Ü.Y, Işık, A, Eliaçık, E, Özcebe, O.İ, Büyükaşık, Y, Sayınalp, N, Aksu, S

Get full text

PP-058 MYASTENIA GRAVIS AND WALDENSTROM MACROGLOBULINEMIA: IS COMMON IMMUNOLOGIC MECHANISM POSSIBLE? by Malkan, Ü.Y, Güneş, G, Işık, A, Eliaçık, E, Sayınalp, N, Demiroğlu, H, Göker, H, Haznedaroğlu, İ

Get full text

PP-040 IS THE BURKITT LEUKEMIA PROGNOSIS AS GOOD AS EXPECTED? by Malkan, Ü.Y, Güneş, G, Işık, A, Eliaçık, E, Balaban, M. Seda, Aslan, T, EtgÜL, S, Sayinalp, N, Aksu, S, Özcebe, O.İ, Demiroğlu, H, Haznedaroğlu, I.C, Göker, H, Büyükaşık, Y

Get full text

PP-025 ADVANCED PHASE CHRONIC MYELOID LEUKEMIA RESISTANT TO IMATINIB, NILOTINIB, DASATINIB AND INTERFERON WITHOUT ABL KINASE MUTATION by Malkan, Ü.Y, Güneş, G, Eliaçık, E, Işık, A, Sayınalp, N, Aksu, S, Haznedaroğlu, İ

Get full text

Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation by Aksu, Salih, Buyukasik, Y., Ozcebe, O., Haznedaroglu, Ibrahim C., Uz, B., Sayinalp, N., Sayitoglu, M., Erbilgin, Y., Bektas, O., Eliacık, E., Goker, H.

“…The current treatment of chronic phase chronic myeloid leukemia (CML) consists of oral tyrosine kinase inhibitors (TKIs). However, high-risk CML may present…”
Get full text

Treatment of pyoderma gangrenosum with thalidomide in a myelodysplastic syndrome case by Malkan, Umit Yavuz, Gunes, Gursel, Eliacik, Eylem, Haznedaroglu, Ibrahim Celalettin

“…Thalidomide may be used as a treatment option for pyoderma gangrenosum (PG) and myelodysplastic syndrome (MDS). Herein, we aimed to report a patient who was…”
Get full text

Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation by Uz, B, Bektas, O, Eliacık, E, Goker, H, Erbilgin, Y, Sayitoglu, M, Sayinalp, N, Aksu, S, Buyukasik, Y, Ozcebe, O, Haznedaroglu, I C

Get full text